Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
about
Evaluation of the efficacy and safety of a neoadjuvant gemcitabine and nedaplatin regimen followed by radiotherapy or concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma.Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial.Matched analysis of induction chemotherapy plus chemoradiotherapy versus induction chemotherapy plus radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a multicenter studySafety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trial.Treatment outcomes for different subgroups of nasopharyngeal carcinoma patients treated with intensity-modulated radiation therapySurvival analyses correlate stanniocalcin 2 overexpression to poor prognosis of nasopharyngeal carcinomas.Prognostic value of pretreatment serum levels of lactate dehydrogenase in nonmetastatic nasopharyngeal carcinoma: single-site analysis of 601 patients in a highly endemic area.The role of concurrent chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal carcinoma among endemic population: a meta-analysis of the phase III randomized trialsExpression of BRCA1 and ERCC1 as predictive clinical outcome after radiochemotherapy in patients with locoregionally moderate-advanced nasopharyngeal carcinomaMolecular prognostic prediction for locally advanced nasopharyngeal carcinoma by support vector machine integrated approachDown-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells.Epstein-Barr virus BALF3 mediates genomic instability and progressive malignancy in nasopharyngeal carcinoma.Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy followed by radiation in patients with advanced nasopharyngeal carcinoma in endemic area: experience of 128 consecutive cases with 5 year follow-upOverexpression of FOXM1 is associated with metastases of nasopharyngeal carcinomaULK1: a promising biomarker in predicting poor prognosis and therapeutic response in human nasopharygeal carcinomaMiR-145 inhibits metastasis by targeting fascin actin-bundling protein 1 in nasopharyngeal carcinomaPropensity-matched analysis of three different chemotherapy sequences in patients with locoregionally advanced nasopharyngeal carcinoma treated using intensity-modulated radiotherapy.Locoregionally advanced nasopharyngeal carcinoma treated with intensity-modulated radiotherapy plus concurrent weekly cisplatin with or without neoadjuvant chemotherapy.H3K27me3 protein is a promising predictive biomarker of patients' survival and chemoradioresistance in human nasopharyngeal carcinomaEfficacy of the Additional Neoadjuvant Chemotherapy to Concurrent Chemoradiotherapy for Patients with Locoregionally Advanced Nasopharyngeal Carcinoma: a Bayesian Network Meta-analysis of Randomized Controlled Trials.Pretreatment Diffusion-Weighted MRI Can Predict the Response to Neoadjuvant Chemotherapy in Patients with Nasopharyngeal Carcinoma.Expression of human leukocyte antigen G is associated with prognosis in nasopharyngeal carcinoma.State-of-the-art management of nasopharyngeal carcinoma: current and future directionsIs Gemcitabine and Cisplatin Induction Chemotherapy Superior in Locoregionally Advanced Nasopharyngeal Carcinoma?Patterns of care for patients with nasopharyngeal carcinoma (KROG 11-06) in South KoreaNeoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated RadiotherapyFunctional elucidation of miR-494 in the tumorigenesis of nasopharyngeal carcinoma.Expression of heat shock protein 70 in nasopharyngeal carcinomas: different expression patterns correlate with distinct clinical prognosisCurrent and emerging treatment options for nasopharyngeal carcinoma.Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.Neoadjuvant chemotherapy plus intensity-modulated radiotherapy versus concurrent chemoradiotherapy plus adjuvant chemotherapy for the treatment of locoregionally advanced nasopharyngeal carcinoma: a retrospective controlled studyThe Predictive Value of Pretreatment (18)-F-FDG-PET-CT in Locally Advanced Nasopharyngeal Cancer Patients Treated Definitively with Induction Chemotherapy Followed by Concurrent Chemo-Radiotherapy.Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy.Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions.Outcomes of Induction Chemotherapy Plus Intensity-Modulated Radiotherapy (IMRT) Versus IMRT Plus Concurrent Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma: A Propensity Matched StudyNimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis.Comparing treatment outcomes of different chemotherapy sequences during intensity modulated radiotherapy for advanced N-stage nasopharyngeal carcinoma patients.Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma.Long-term clinical outcome in nasopharyngeal carcinoma patients with post-radiation persistently detectable plasma EBV DNA.Increased expression of SHP-1 is associated with local recurrence after radiotherapy in patients with nasopharyngeal carcinoma
P2860
Q33428012-63B8C67E-CCE3-49A3-9959-0A1285766167Q33435906-531BC2BD-2D23-4229-A599-F3E3E0D9D7A9Q33436774-1769DA47-9BF2-49CD-BB52-AB6B44098AFEQ33439337-0E9BCA7E-6C95-43BF-91B8-9B64D1E20148Q33579689-1A72E2E8-4296-46BE-A7C3-34D4845BD4C7Q33587519-1F21E3E2-D3A4-4F26-AEC9-FFC12A63EF3AQ33650637-60285EA9-E547-4833-83C5-F1FB6AD82F2CQ33719825-3CE07451-F9DD-41F8-9B52-138C91EC3B6BQ33761748-8DB4688E-6E07-4134-98F4-055AAEAACCB6Q34199695-209A3C1E-81EA-46C2-8DB5-0A2DDA957CD2Q34371119-6B775099-F7B5-4FDE-A8BF-331D4E70878BQ34483687-FFAEF436-5B10-49E9-9CBD-A955C47200E4Q34492567-F65BC873-456B-40A5-AA47-5F3C9EF927FDQ34589178-977DF9B6-2A73-4557-ADBA-374F61B489AAQ35122866-5834FB26-C3DB-4BD4-9EB3-A049D749C011Q35225191-9E4FD4A1-5FF4-43AA-B63A-27F686388A1BQ35823316-0FD04A77-C090-4C7A-87FF-1D82B3DE1F5CQ35824278-84DE90A6-86E1-4A30-B37C-F670A638521EQ35876813-10D11E79-0C10-4F1E-91B5-59DCC56E5EC3Q35942191-E837FA20-B3C6-4974-994E-E65AE6078B2AQ36043428-590E357E-2420-44CA-B8AF-A051EFA77A86Q36063731-23CA8B83-FBDE-421E-83E7-8F6094219E3FQ36065641-AA0D5438-3437-4D69-ACAA-1E19FDA853CBQ36111085-DCF2255C-BEFA-4070-A355-C5D2A6306B72Q36166868-E71B482F-5076-4EEC-A50B-724222887934Q36174879-E9CEEDB2-AB6D-4682-9C96-68AFB97A39B8Q36278144-69B28876-0300-4BF5-9131-D68E33544FDAQ36338606-14DFCFE2-8B9E-457D-8AA3-FF36E1C8220BQ36359374-7C87DF22-269E-4D92-8797-BAC355BC815CQ36407458-1C452D3A-1AD2-4ACC-9788-5724B5D91A9BQ36439727-E9EAA1DF-15F8-4EC0-872C-86E218E11661Q36467986-31F55FF6-9E06-404C-851D-B67A589DCA3AQ36629614-A15DADC6-F913-45F0-A859-89A1BAAD9BCDQ37171008-3F9554F2-1E7A-424A-A7B8-81F9F0E8C1A2Q37221893-A8D5B0F9-83A0-4605-9C62-11437DA86210Q37269328-EB3868AF-7410-4AA6-BCE9-2A04EDC94718Q37348334-E772091B-C242-45DA-8F19-8B38DE2EE55DQ37353983-4492FB5A-D778-4449-AB8D-1D16EC744E46Q37520639-63EFAF9C-2396-408A-9D72-636F85CDB201Q37537888-9BED27E7-EDC5-43E0-B685-DA0C313E523D
P2860
Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Long-term survival after cispl ...... lysis of two phase III trials.
@ast
Long-term survival after cispl ...... lysis of two phase III trials.
@en
type
label
Long-term survival after cispl ...... lysis of two phase III trials.
@ast
Long-term survival after cispl ...... lysis of two phase III trials.
@en
prefLabel
Long-term survival after cispl ...... lysis of two phase III trials.
@ast
Long-term survival after cispl ...... lysis of two phase III trials.
@en
P2093
P921
P356
P1476
Long-term survival after cispl ...... lysis of two phase III trials.
@en
P2093
Damon T K Choy
Daniel T T Chua
Hai-Qiang Mai
Hua-Qing Min
Jonathan S T Sham
Ming-Huang Hong
Tai-Xiang Lu
P304
P356
10.1200/JCO.2005.12.081
P407
P50
P577
2005-01-18T00:00:00Z